{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:10:02Z","timestamp":1781611802928,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Due to the burden of schistosomiasis (SCH) and soil-transmitted helminths (STH), Togo Ministry of Health launched a program for Preventive Chemotherapy Neglected Tropical Diseases (PC-NTDs) in 2009, initiating integrated mass drug administration (MDA) the following year for the three PC-NTDs: SCH, STH and onchocerciasis. Significant reduction of infection across the country was noted in 2015 during the first impact assessment, following 5 years of high-coverage MDA implemented at the sub-district level for SCH and district level for STH. After another 5 years of effective MDA, a second survey was conducted in 2021 to re-evaluate the situation of SCH and STH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cross-section of school-aged children was taken across ten districts of Togo. A total of 302 schools in 92 sub-districts were sampled, with 24 school-aged children per school resulting in 7248 children surveyed. Urine samples were tested by haemastix\u00ae for <jats:italic>Schistosoma haematobium<\/jats:italic>, with urine filtration for the presence of eggs conducted on haematuria-positive samples. Stool samples were collected in a subset of 34 sub-districts in seven out of the ten surveyed districts, where STH and <jats:italic>Schistosoma mansoni<\/jats:italic> endemicity was high during the 2015 impact assessment. Duplicate (two) Kato-Katz analysis was performed for each stool sample. Sociodemographic and school-level water, sanitation and hygiene information was also collected.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, SCH prevalence was 5.90% (95% CI: 5.4\u20136.5), with 5.09% (95% CI: 4.64\u20135.67) for <jats:italic>S. haematobium<\/jats:italic> and 2.56% (95% CI: 1.98\u20133.29) for <jats:italic>S. mansoni<\/jats:italic>. STH prevalence was 19.7% (95% CI: 18.2\u201321.4), with 19.6% (95% CI: 18.1\u201321.3) hookworm, 0.08% (95% CI: 2.2\u20135.8) <jats:italic>Trichuris trichiura<\/jats:italic> and 0.04% (95% CI: 0.01\u20130.33) <jats:italic>Ascaris lumbricoides<\/jats:italic>. Compared to baseline, a significant reduction in both SCH (22.2% to 5.90%) and STH (29.2% t0 19.7%) prevalence was observed. Children aged 5\u20139\u00a0years were less infected than older peers aged 10\u201314\u00a0years: 4.76% vs. 7.53% (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01) for SCH and 17.2% vs. 23.0% (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01) for STH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>After 10 years of high coverage integrated MDA, Togo has achieved low prevalence SCH infection through the sub-district MDA implementation with considerable infection heterogeneity within sub-districts. As STH infection has not reached a level where the infections are not a public health problem, the sub-district treatment strategy could also be adopted in addition to improvement of treatment coverage among preschool age children and hygiene and sanitation practices.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13071-023-05882-2","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T13:02:56Z","timestamp":1693832576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Progress from morbidity control to elimination as a public health problem of schistosomiasis and the status of soil-transmitted helminth infection in Togo: a second impact assessment after ten rounds of mass drug administration"],"prefix":"10.1186","volume":"16","author":[{"given":"Ameyo M.","family":"Dorkenoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna E.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiali","family":"Lack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Essoham","family":"Ataba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kossi","family":"Yakpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atna-Edi","family":"Tagba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bozi-Esso","family":"Assoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efoe","family":"Sossou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maw\u00e8k\u00e9","family":"Tchalim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gbati","family":"Datagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Seim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Denise","family":"Milord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Kassankogno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"5882_CR1","unstructured":"WHO. WHO|Global Schistosomiasis Atlas. WHO. World Health Organization; 2016; https:\/\/www.who.int\/schistosomiasis\/epidemiology\/global_atlas\/en\/"},{"key":"5882_CR2","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1186\/1756-3305-7-37","volume":"7","author":"RL Pullan","year":"2014","unstructured":"Pullan RL, Smith JL, Jasrasaria R, Brooker SJ. Global numbers of infection and disease burden of soil transmitted helminth infections in 2010. Parasit Vectors. 2014;7:1756\u20133305.","journal-title":"Parasit Vectors"},{"key":"5882_CR3","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1172\/JCI34261","volume":"118","author":"PJ Hotez","year":"2008","unstructured":"Hotez PJ, Brindley PJ, Bethony JM, King CH, Pearce EJ, Jacobson J. Helminth infections: the great neglected tropical diseases. J Clin Invest. 2008;118:1311\u201321.","journal-title":"J Clin Invest"},{"key":"5882_CR4","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","volume":"383","author":"DG Colley","year":"2014","unstructured":"Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet. 2014;383:2253\u201364.","journal-title":"Lancet"},{"key":"5882_CR5","volume-title":"Helminth control in school-age children. A guide for managers of control programmes","author":"World Health Organization","year":"2011","unstructured":"World Health Organization. Helminth control in school-age children. A guide for managers of control programmes. Geneva: World Health Organization; 2011."},{"key":"5882_CR6","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1179\/000349802125001735","volume":"96","author":"JO Gyapong","year":"2002","unstructured":"Gyapong JO, Kyelem D, Kleinschmidt I, Agbo K, Ahouandogbo F, Gaba J, et al. The use of spatial analysis in mapping the distribution of bancroftian filariasis in four West African countries. Ann Trop Med Parasitol. 2002;96:695\u2013705.","journal-title":"Ann Trop Med Parasitol"},{"key":"5882_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13071-017-2611-9","volume":"11","author":"MA Dorkenoo","year":"2018","unstructured":"Dorkenoo MA, de Souza DK, Apetogbo Y, Oboussoumi K, Yehadji D, Tchalim M, et al. Molecular xenomonitoring for post-validation surveillance of lymphatic filariasis in Togo: no evidence for active transmission. Parasites Vectors. 2018;11:52.","journal-title":"Parasites Vectors"},{"key":"5882_CR8","doi-asserted-by":"publisher","first-page":"e0006312","DOI":"10.1371\/journal.pntd.0006312","volume":"12","author":"K Komlan","year":"2018","unstructured":"Komlan K, Vossberg PS, Gantin RG, Solim T, Korbmacher F, Banla M, et al. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin. PloS Negl Trop Dis. 2018;12:e0006312.","journal-title":"PloS Negl Trop Dis"},{"key":"5882_CR9","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/j.1365-3156.2012.03004.x","volume":"17","author":"AM Dorkenoo","year":"2012","unstructured":"Dorkenoo AM, Bronzan RN, Ayena KD, Anthony G, Agbo YM, Sognikin KS, et al. Nationwide integrated mapping of three neglected tropical diseases in Togo: countrywide implementation of a novel approach. Trop Med Int Health. 2012;17:896\u2013903.","journal-title":"Trop Med Int Health"},{"key":"5882_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006551","volume":"12","author":"RN Bronzan","year":"2018","unstructured":"Bronzan RN, Dorkenoo AM, Agbo YM, Halatoko W, Layibo Y, Adjeloh P, et al. Impact of community-based integrated mass drug administration on schistosomiasis and soil-transmitted helminth prevalence in Togo. PLoS Negl Trop Dis. 2018;12:e0006551.","journal-title":"PLoS Negl Trop Dis"},{"key":"5882_CR11","doi-asserted-by":"publisher","first-page":"e0005599","DOI":"10.1371\/journal.pntd.0005599","volume":"11","author":"SC Knowles","year":"2017","unstructured":"Knowles SC, Sturrock HJ, Turner H, Whitton JM, Gower CM, Jemu S, et al. Optimising cluster survey design for planning schistosomiasis preventive chemotherapy. PLoS Negl Trop Dis. 2017;11:e0005599.","journal-title":"PLoS Negl Trop Dis"},{"key":"5882_CR12","unstructured":"Montresor A,\u00a0Crompton DWT, Gyorkos TW, Savioli L, World Health Organization. Helminth control in school-age children: a guide for managers of control programmes\/A. Montresor ... [\u200eet al.]\u200e. 2002. World Health Organization.\u00a0https:\/\/apps.who.int\/iris\/handle\/10665\/42473"},{"key":"5882_CR13","unstructured":"WHO\/UNICEF WHO\/UNICEF Joint Monitoring Programme (JMP) for Water Supply and Sanitation. https:\/\/washdata.org\/. Accessed 6 Oct 2021."},{"key":"5882_CR14","unstructured":"WHO. WHO guideline on control and elimination of human schistosomiasis. 2022; https:\/\/www.who.int\/publications\/i\/item\/9789240041608. Accessed 30 Jan 2023."},{"key":"5882_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-015-1165-y","volume":"8","author":"SJ Krauth","year":"2015","unstructured":"Krauth SJ, Greter H, Stete K, Coulibaly JT, Traor\u00e9 SI, Ngandolo BN, et al. All that is blood is not schistosomiasis: experiences with reagent strip testing for urogenital schistosomiasis with special consideration to very-low prevalence settings. Parasit Vectors. 2015;8:1.","journal-title":"Parasit Vectors"},{"key":"5882_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002431","volume":"7","author":"CH King","year":"2013","unstructured":"King CH, Bertsch D. Meta-analysis of urine heme dipstick diagnosis of Schistosoma haematobium infection, including low-prevalence and previously-treated populations. PLoS Negl Trop Dis. 2013;7:e2431.","journal-title":"PLoS Negl Trop Dis"},{"key":"5882_CR17","doi-asserted-by":"publisher","first-page":"e1001620","DOI":"10.1371\/journal.pmed.1001620","volume":"11","author":"EC Strunz","year":"2014","unstructured":"Strunz EC, Addiss DG, Stocks ME, Ogden S, Utzinger J, Freeman MC. Water, sanitation, hygiene, and soil-transmitted helminth infection: a systematic review and meta-analysis. PLoS Med. 2014;11:e1001620.","journal-title":"PLoS Med"},{"key":"5882_CR18","doi-asserted-by":"publisher","first-page":"e2651","DOI":"10.1371\/journal.pntd.0002651","volume":"8","author":"SJ Campbell","year":"2014","unstructured":"Campbell SJ, Savage GB, Gray DJ, Atkinson JA, Soares Magalh\u00e3es RJ, Nery SV, et al. Water, sanitation, and hygiene (WASH): a critical component for sustainable soil-transmitted helminth and schistosomiasis control. PLoS Negl Trop Dis. 2014;8:e2651.","journal-title":"PLoS Negl Trop Dis"},{"key":"5882_CR19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S1473-3099(21)00090-6","volume":"22","author":"C Kokaliaris","year":"2022","unstructured":"Kokaliaris C, Garba A, Matuska M, Bronzan RN, Colley DG, Dorkenoo AM, et al. Effect of preventive chemotherapy with praziquantel on schistosomiasis among school-aged children in sub-Saharan Africa: a spatiotemporal modelling study. Lancet Infect Dis. 2022;22:136\u201349.","journal-title":"Lancet Infect Dis"},{"key":"5882_CR20","doi-asserted-by":"publisher","first-page":"617","DOI":"10.4269\/ajtmh.19-0193","volume":"101","author":"N Kittur","year":"2019","unstructured":"Kittur N, King CH, Campbell CH, Kinung\u2019hi S, Mwinzi PNM, Karanja DMS, et al. Persistent hotspots in Schistosomiasis consortium for operational research and evaluation studies for gaining and sustaining control of schistosomiasis after four years of mass drug administration of praziquantel. Am J Trop Med Hyg. 2019;101:617\u201327.","journal-title":"Am J Trop Med Hyg"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-023-05882-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-023-05882-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-023-05882-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T22:25:30Z","timestamp":1700346330000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-023-05882-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5882"],"URL":"https:\/\/doi.org\/10.1186\/s13071-023-05882-2","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,4]]},"assertion":[{"value":"12 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for this study was received from Togo MOH Bioethics Committee for Health Research of the Togo Ministry of Health (approval number: 037\/2021\/CBRS of the Ministry of Health of Togo). Written informed consent was obtained from the parent or guardian of each child enrolled in this study. A child assent form was developed for the participating children to read so that they could understand the procedures and objectives of the study. Additional permission was sought from national, regional and district administrative authorities in the regions concerned. The unique codes were assigned to each participant, which were used to identify them for the purposes of this study instead of their names. All study records were kept in a secure room by the principal investigator (PI). All children who tested positive were referred to the health center for treatment according to WHO recommendations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"314"}}